Efficacy of Atomoxetine in the Neuropsychological Tests Among Children With ADHD [attention-deficit hyperactivity disorder]
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 18 Oct 2013
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 18 Oct 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Oct 2007 New trial record.